- (-)
- -
- -
- -
- -
- -
Last
- - (-%)Volume
-52 Week Range
-
Key Stats
Open -
Day High -
Day Low -
Previous Close -
52 Week High -
52 Week Low -
50 Day Average -
200 Day Average -
Market Cap -
Shares Out -
Book Value -
Ratios/Profitability
EPS -
P/E -
P/B -
Events
Earnings Date -
Latest News
Gilead’s Covid-19 treatment has been approved by the FDA
October 23, 2020
The Food and Drug Administration, or FDA on Thursday announced that it had approved Gilead Sciences’ remdesivir as a coronavirus treatment. Following the announcement, shares of Gilead we...
Gilead’s Remdesivir Gets FDA Approval
May 04, 2020
On Friday, President Trump announced that the remdesivir, an antiviral treatment developed by Gilead Sciences, had been authorized by the Food and Drug Administration (FDA) as an emergency treatment f...
Gilead Sciences drug shows promising result during the coronavirus treatment, stock soars
April 20, 2020
When the COVID-19 pandemic recently broke out in the US, a few pharmaceuticals took it upon themselves to develop a vaccine or treatment for the coronavirus, and Gilead Sciences was one of the fore-ru...